Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > losing patience
View:
Post by kalman007 on Feb 04, 2022 1:48pm

losing patience

just reviewing the various posts on this bulletin board tells me that everyone is losing patience with this company and its management.  The SP performance is lackluster at best, they've been at this game long enough and have nothing to take to market.  I realize that Rome wasn't built in a day, and certainly developing a drug that could literally change the world needs time.  But since the onset of PMN310, nothing seems to have gone as planned with testing and clinical trial and USDA approval being delayed eternally has to make you wonder if in fact there is something real.  Keeping us in the dark will result in losing investor confidence which will then sink the ship.  Adding names to the board is "ho hum" news at best.  What we need NOW are results!!!!!!!!
Comment by DavidKingCanada on Feb 04, 2022 3:09pm
Amen!
Comment by M101 on Feb 04, 2022 4:08pm
I agree with the sentiment, but it is based on the 2015-16 comments not promises of the consultants who stood to gain most by an early exit. We now know that no big pharma player was ever going to bet early on the misfolded-protein-only epitope hypothesis, not because there's anything wrong with it but because they simply don't take those kinds of risks except as developed in-house, and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities